{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T05:25:38Z","timestamp":1732771538728,"version":"3.29.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00391-024-02375-4","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T08:47:55Z","timestamp":1731055675000},"page":"659-667","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Update Vorhofflimmern bei geriatrischen Patienten","Update atrial fibrillation in older adults"],"prefix":"10.1007","volume":"57","author":[{"given":"M.","family":"Gosch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Habboub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. N.","family":"Krohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pauschinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Deneke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"issue":"2","key":"2375_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1532-5415.2005.53105.x","volume":"53","author":"AM Arnold","year":"2005","unstructured":"Arnold\u00a0AM, Psaty\u00a0BM, Kuller\u00a0LH, Burke\u00a0GL, Manolio\u00a0TA, Fried\u00a0LP et\u00a0al (2005) Incidence of cardiovascular disease in older Americans: the cardiovascular health study. J\u00a0Am Geriatr Soc 53(2):211\u2013218","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"2375_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1160\/TH13-02-0165","volume":"110","author":"N Lowres","year":"2013","unstructured":"Lowres\u00a0N, Neubeck\u00a0L, Redfern\u00a0J, Freedman\u00a0SB (2013) Screening to identify unknown atrial fibrillation. A\u00a0systematic review. Thromb Haemost 110(2):213\u2013222","journal-title":"Thromb Haemost"},{"issue":"40","key":"2375_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta9400","volume":"9","author":"FD Hobbs","year":"2005","unstructured":"Hobbs\u00a0FD, Fitzmaurice\u00a0DA, Mant\u00a0J, Murray\u00a0E, Jowett\u00a0S, Bryan\u00a0S et\u00a0al (2005) A\u00a0randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess 9(40):1\u201374","journal-title":"Health Technol Assess"},{"issue":"2","key":"2375_CR4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00391-023-02177-0","volume":"57","author":"M Gotze","year":"2024","unstructured":"Gotze\u00a0M, Ebelt\u00a0H (2024) Prevalence, incidence and predictive factors of atrial fibrillation in geriatric patients\u2014A prospective observational study. Z\u00a0Gerontol Geriatr 57(2):120\u2013125","journal-title":"Z Gerontol Geriatr"},{"key":"2375_CR5","first-page":"1","volume":"00","author":"G Hindricks","year":"2020","unstructured":"Hindricks\u00a0G, Potpara\u00a0T, Dagres\u00a0N, Arbelo\u00a0E, Bax\u00a0JJ, Blomstr\u00f6m-Lundqvist\u00a0C, Boriani\u00a0G, Castella\u00a0M, Dan\u00a0GA, Dilaveris\u00a0PE, Fauchier\u00a0L, filipppatos\u00a0G, Kalman\u00a0JM, La Meir\u00a0M. (2020) ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 00:1\u2013125","journal-title":"Eur Heart J"},{"issue":"2","key":"2375_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","volume":"63","author":"RL Howard","year":"2007","unstructured":"Howard\u00a0RL, Avery\u00a0AJ, Slavenburg\u00a0S, Royal\u00a0S, Pipe\u00a0G, Lucassen\u00a0P et\u00a0al (2007) Which drugs cause preventable admissions to hospital? A\u00a0systematic review. Br J Clin Pharmacol 63(2):136\u2013147","journal-title":"Br J Clin Pharmacol"},{"key":"2375_CR7","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2147\/CIA.S162701","volume":"13","author":"A Chudiak","year":"2018","unstructured":"Chudiak\u00a0A, Uchmanowicz\u00a0I, Mazur\u00a0G (2018) Relation between cognitive impairment and treatment adherence in elderly hypertensive patients. Clin Interv Aging 13:1409\u20131418","journal-title":"Clin Interv Aging"},{"issue":"2","key":"2375_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/europace\/euac155","volume":"25","author":"SC Chung","year":"2023","unstructured":"Chung\u00a0SC, Lai\u00a0A, Lip\u00a0GYH, Lambiase\u00a0PD, Providencia\u00a0R (2023) Impact of anti-arrhythmic drugs and catheter ablation on the survival of patients with atrial fibrillation: a\u00a0population study based on 199 433 new-onset atrial fibrillation patients in the UK. Europace 25(2):351\u2013359","journal-title":"Europace"},{"issue":"4","key":"2375_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2029980","volume":"384","author":"JG Andrade","year":"2021","unstructured":"Andrade\u00a0JG, Wells\u00a0GA, Deyell\u00a0MW, Bennett\u00a0M, Essebag\u00a0V, Champagne\u00a0J et\u00a0al (2021) Cryoablation or drug therapy for initial treatment of atrial fibrillation. N\u00a0Engl J Med 384(4):305\u2013315","journal-title":"N Engl J Med"},{"issue":"14","key":"2375_CR10","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","volume":"383","author":"P Kirchhof","year":"2020","unstructured":"Kirchhof\u00a0P, Camm\u00a0AJ, Goette\u00a0A, Brandes\u00a0A, Eckardt\u00a0L, Elvan\u00a0A et\u00a0al (2020) Early rhythm-control therapy in patients with atrial fibrillation. N\u00a0Engl J Med 383(14):1305\u20131316","journal-title":"N Engl J Med"},{"issue":"11","key":"2375_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1161\/CIRCULATIONAHA.122.060274","volume":"146","author":"A Rillig","year":"2022","unstructured":"Rillig\u00a0A, Borof\u00a0K, Breithardt\u00a0G, Camm\u00a0AJ, Crijns\u00a0H, Goette\u00a0A et\u00a0al (2022) Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden. Circulation 146(11):836\u2013847","journal-title":"Circulation"},{"issue":"23","key":"2375_CR12","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.121.057095","volume":"145","author":"R Parkash","year":"2022","unstructured":"Parkash\u00a0R, Wells\u00a0GA, Rouleau\u00a0J, Talajic\u00a0M, Essebag\u00a0V, Skanes\u00a0A et\u00a0al (2022) Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial. Circulation 145(23):1693\u20131704","journal-title":"Circulation"},{"issue":"10","key":"2375_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/jama.2023.14685","volume":"330","author":"AM Al-Kaisey","year":"2023","unstructured":"Al-Kaisey\u00a0AM, Parameswaran\u00a0R, Bryant\u00a0C, Anderson\u00a0RD, Hawson\u00a0J, Chieng\u00a0D et\u00a0al (2023) Atrial Fibrillation Catheter Ablation vs Medical Therapy and Psychological Distress: A\u00a0Randomized Clinical Trial. JAMA 330(10):925\u2013933","journal-title":"JAMA"},{"key":"2375_CR14","doi-asserted-by":"crossref","unstructured":"Boehmer AA, Rothe M, Zezyk C, Soether CM, Dobre BC, Kaess BM et\u00a0al (2022) Persistent Atrial Fibrillation in Elderly Patients: Limited Efficacy of Pulmonary Vein Isolation. J\u00a0Clin Med 11(20)","DOI":"10.3390\/jcm11206070"},{"key":"2375_CR15","doi-asserted-by":"crossref","unstructured":"Oates CP, Basyal B, Whang W, Reddy VY, Koruth JS (2024) Trends in safety of catheter-based electrophysiology procedures in the last 2\u00a0decades: A\u00a0meta-analysis. Heart Rhythm","DOI":"10.1016\/j.hrthm.2024.03.043"},{"issue":"9","key":"2375_CR16","first-page":"563","volume":"14","author":"J Kautzner","year":"2017","unstructured":"Kautzner\u00a0J, Peichl\u00a0P, Sramko\u00a0M, Cihak\u00a0R, Aldhoon\u00a0B, Wichterle\u00a0D (2017) Catheter ablation of atrial fibrillation in elderly population. J\u00a0Geriatr Cardiol 14(9):563\u2013568","journal-title":"J Geriatr Cardiol"},{"issue":"6","key":"2375_CR17","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jacep.2024.02.022","volume":"10","author":"JN Catanzaro","year":"2024","unstructured":"Catanzaro\u00a0JN, Assis\u00a0FR, Verma\u00a0A, Tandri\u00a0H, Tilz\u00a0RR, Spragg\u00a0DD et\u00a0al (2024) Recognition, Management, and Prevention of Atrioesophageal Fistula. JACC Clin Electrophysiol 10(6):1232\u20131241","journal-title":"JACC Clin Electrophysiol"},{"issue":"27","key":"2375_CR18","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1093\/eurheartj\/ehad250","volume":"44","author":"RR Tilz","year":"2023","unstructured":"Tilz\u00a0RR, Schmidt\u00a0V, Purerfellner\u00a0H, Maury\u00a0P, Chun\u00a0K, Martinek\u00a0M et\u00a0al (2023) A\u00a0worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study. Eur Heart\u00a0J 44(27):2458\u20132469","journal-title":"Eur Heart J"},{"issue":"8","key":"2375_CR19","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/europace\/euac050","volume":"24","author":"E Ekanem","year":"2022","unstructured":"Ekanem\u00a0E, Reddy\u00a0VY, Schmidt\u00a0B, Reichlin\u00a0T, Neven\u00a0K, Metzner\u00a0A et\u00a0al (2022) Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF). Europace 24(8):1256\u20131266","journal-title":"Europace"},{"issue":"3","key":"2375_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/heartjnl-2011-300550","volume":"98","author":"PG Steg","year":"2012","unstructured":"Steg\u00a0PG, Alam\u00a0S, Chiang\u00a0CE, Gamra\u00a0H, Goethals\u00a0M, Inoue\u00a0H et\u00a0al (2012) Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry. Heart 98(3):195\u2013201","journal-title":"Heart"},{"issue":"46","key":"2375_CR21","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1093\/eurheartj\/ehab569","volume":"42","author":"M Brignole","year":"2021","unstructured":"Brignole\u00a0M, Pentimalli\u00a0F, Palmisano\u00a0P, Landolina\u00a0M, Quartieri\u00a0F, Occhetta\u00a0E et\u00a0al (2021) AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart\u00a0J 42(46):4731\u20134739","journal-title":"Eur Heart J"},{"issue":"21","key":"2375_CR22","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","volume":"115","author":"EM Hylek","year":"2007","unstructured":"Hylek\u00a0EM, Evans-Molina\u00a0C, Shea\u00a0C, Henault\u00a0LE, Regan\u00a0S (2007) Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115(21):2689\u20132696","journal-title":"Circulation"},{"issue":"19","key":"2375_CR23","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","volume":"125","author":"L Friberg","year":"2012","unstructured":"Friberg\u00a0L, Rosenqvist\u00a0M, Lip\u00a0GY (2012) Net clinical benefit of warfarin in patients with atrial fibrillation: a\u00a0report from the Swedish atrial fibrillation cohort study. Circulation 125(19):2298\u20132307","journal-title":"Circulation"},{"issue":"7","key":"2375_CR24","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/archinte.159.7.677","volume":"159","author":"M Man-Son-Hing","year":"1999","unstructured":"Man-Son-Hing\u00a0M, Nichol\u00a0G, Lau\u00a0A, Laupacis\u00a0A (1999) Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med 159(7):677\u2013685","journal-title":"Arch Intern Med"},{"issue":"11","key":"2375_CR25","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.amjmed.2012.04.005","volume":"125","author":"J Donze","year":"2012","unstructured":"Donze\u00a0J, Rodondi\u00a0N, Waeber\u00a0G, Monney\u00a0P, Cornuz\u00a0J, Aujesky\u00a0D (2012) Scores to predict major bleeding risk during oral anticoagulation therapy: a\u00a0prospective validation study. Am J Med 125(11):1095\u20131102","journal-title":"Am J Med"},{"key":"2375_CR26","doi-asserted-by":"publisher","first-page":"i3189","DOI":"10.1136\/bmj.i3189","volume":"353","author":"TB Larsen","year":"2016","unstructured":"Larsen\u00a0TB, Skjoth\u00a0F, Nielsen\u00a0PB, Kjaeldgaard\u00a0JN, Lip\u00a0GY (2016) Comparative effectiveness and safety of non-vitamin\u00a0K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ 353:i3189","journal-title":"BMJ"},{"issue":"4","key":"2375_CR27","first-page":"279","volume":"149","author":"LPT Joosten","year":"2024","unstructured":"Joosten\u00a0LPT, van Doorn\u00a0S, van de Ven\u00a0PM, Kohlen\u00a0BTG, Nierman\u00a0MC, Koek\u00a0HL et\u00a0al (2024) Safety of Switching From a\u00a0Vitamin\u00a0K Antagonist to a\u00a0Non-Vitamin\u00a0K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial. Circulation 149(4):279\u2013289","journal-title":"Circulation"},{"issue":"3","key":"2375_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/ehjcvp\/pvae016","volume":"10","author":"C Binding","year":"2024","unstructured":"Binding\u00a0C, Blanche\u00a0P, Lip\u00a0GYH, Kamper\u00a0AL, Lee\u00a0CJY, Staerk\u00a0L et\u00a0al (2024) Efficacy and safety of oral anticoagulants according to kidney function among patients with atrial fibrillation. Eur Heart J Cardiovasc Pharmacother 10(3):210\u2013218","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"13","key":"2375_CR29","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","volume":"389","author":"P Kirchhof","year":"2023","unstructured":"Kirchhof\u00a0P, Toennis\u00a0T, Goette\u00a0A, Camm\u00a0AJ, Diener\u00a0HC, Becher\u00a0N et\u00a0al (2023) Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. N\u00a0Engl J Med 389(13):1167\u20131179","journal-title":"N Engl J Med"},{"issue":"2","key":"2375_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2310234","volume":"390","author":"JS Healey","year":"2024","unstructured":"Healey\u00a0JS, Lopes\u00a0RD, Granger\u00a0CB, Alings\u00a0M, Rivard\u00a0L, McIntyre\u00a0WF et\u00a0al (2024) Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. N\u00a0Engl J Med 390(2):107\u2013117","journal-title":"N Engl J Med"},{"key":"2375_CR31","doi-asserted-by":"crossref","unstructured":"Zimerman A, Braunwald E, Steffel J, Van Mieghem NM, Palazzolo MG, Murphy SA et\u00a0al (2024) Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial. JAMA Cardiol","DOI":"10.1001\/jamacardio.2024.1793"},{"key":"2375_CR32","doi-asserted-by":"crossref","unstructured":"Pilotto ANV, Polidori MC, Strandberg T, Topinkova E, Cruz-Jentoft AJ, Custodero C, Barbagallo M, Maggi S (2023) the EUROSAF Study Investigators Frailty and anticoagulants in older subjects with atrial fibrillation: the EUROSAF study. Age Ageing 52(11)","DOI":"10.1093\/ageing\/afad216"},{"key":"2375_CR33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ijcard.2017.08.049","volume":"249","author":"S Gloekler","year":"2017","unstructured":"Gloekler\u00a0S, Saw\u00a0J, Koskinas\u00a0KC, Kleinecke\u00a0C, Jung\u00a0W, Nietlispach\u00a0F et\u00a0al (2017) Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation. Int J Cardiol 249:234\u2013246","journal-title":"Int J Cardiol"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-024-02375-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00391-024-02375-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-024-02375-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T11:09:01Z","timestamp":1732705741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00391-024-02375-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2375"],"URL":"https:\/\/doi.org\/10.1007\/s00391-024-02375-4","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"type":"print","value":"0948-6704"},{"type":"electronic","value":"1435-1269"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>M.\u00a0Gosch: <\/b>A.\u00a0Finanzielle Interessen: Vortragshonorare: Novartis, BMS, Pfizer, Bayer, Daiichi-Sankyo. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Pr\u00e4sident der Deutschen Gesellschaft f\u00fcr Geriatrie. <b>B.\u00a0Habboub:<\/b> A.\u00a0Finanzielle Interessen: B.\u00a0Habboub gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Assistenzarzt, Doktorand und Epidemiologie-Dozent, Klinik f\u00fcr Innere Medizin\u00a0II \u2013\u00a0Schwerpunkt f\u00fcr Geriatrie Klinikum N\u00fcrnberg und Universit\u00e4tsklinik der Paracelsus Medizinischen Privatuniversit\u00e4t | Mitgliedschaften: Gesellschaften: DGG, DTG, DGIM, Berufsverb\u00e4nde: Marburger Bund. <b>M.\u00a0Pauschinger: <\/b>A.\u00a0Finanzielle Interessen: M.\u00a0Pauschinger gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Klinikdirektor der Med. Klinik\u00a08 \u2013\u00a0Kardiologie, Universit\u00e4tsklinik der Paracelsus Medizinischen Privatuniversit\u00e4t, Klinikum N\u00fcrnberg | Mitgliedschaft: Deutsche Gesellschaft f\u00fcr Kardiologie. <b>T.\u00a0Deneke: <\/b>A.\u00a0Finanzielle Interessen: Referentenhonorar: Biotronik, Abbott.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: angestellter Arzt, Rh\u00f6n-Klinikum Campus Bad Neustadt und Klinikum N\u00fcrnberg S\u00fcd | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Kardiologie, European Heart Rhythm Society, Heart Rhythm Society. <b>J.N.\u00a0Krohn<\/b> gibt an, dass kein Interessenkonflikt besteht.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}